The Hon Verity Firth MP, Minister for Climate Change and the Environment | Minister for Women | Minister for Science & Medical Research | Minister Assisting the Minister for Health (Cancer)

Combining Toll-like receptor agonists and immune costimulation for cancer therapy

Dr Michael Kershaw, Peter MacCallum Cancer Centre, VIC

 

IAPs and their antagonists - from baculovirus to bedside
Dr David Vaux, La Trobe Unviersity, VIC

Combined gene directed enzyme prodrug therapy with and immunostimulatory cytokines (interleukins-12 and -18) for treating prostate cancer in immunocompetent mice

Professor Pamela Russell,  Prince of Wales Hospital, NSW

 

Finding new low penetrance melanoma predisposition genes: is it all about pigmentation?
Dr Nick Hayward, Queensland Institute of Medical Rsesearch, QLD

Telomeres and telomerase

Professor Elizabeth Blackburn, University of California, CA, USA

Professor Blackburn is the world leader of telomere and telomerase research. She has received over forty awards including the most prestigious Albert Lasker Award (which frequently precedes a Nobel Prize in Medicine) and is listed among Time Magazine’s 100 Most Influential People in the World!!!

Vascular normalization in regulator of G protein signalling 5-deficient tumours promotes immune destruction
Associate Professor Ruth Ganss, Western Australian Institute for Medical Research, WA 

Targeting the stem cell niche in prostate cancer
Professor Gail Risbridger, Monash Institute of Medical Research, VIC

Molecular regulation of the pro-metastatic protein HEF1
Dr Geraldine O'Neill, Children's Hospital, Westmead, NSW  

 

Integrin-targetted cancer therapy 
Dr Michael Agrez,  INTER-K Pty Ltd, NSW   

 

Genomic approaches to understanding gastric cancer progression
Assoc Prof Patrick Tan, Duke-NUS Graduate Medical School, SG

 

On which battlefields will the war on prostate cancer be won?
Professor Jim Denham, The University of Newcastle, NSW

The impact of inflammation on cancer drug metabolism and toxicity
Professor Stephen Clarke, University of Sydney, NSW 

10.30am           Morning Tea and Poster Viewing

Surveying signaling pathway activity in cancer
Professor Michael Comb, Cell Signaling Technology, Inc., MA, USA

 

Prognostic biomarker discovery in colorectal cancer using proteomics
Associate Professor Mark Molloy, Australian Proteome Analysis Facility, NSW

 

Epigenomics: an emerging field in cancer research
Professor Susan Clark, Garvan Institute of Medical Research, NSW

 

Approaches to pharmacogenomics in early phase oncology trials
Dr Joel Greshock, GlaxoSmithKline, PA, USA

 

Molecular targeted therapy for childhood neuroblastoma
Professor Michelle Haber, Children's Cancer Institute Australia, NSW

 

Parp inhibitor drug development program

Dr Clare Scott, Walter and Eliza Hall Institute of Medical Research, VIC

 

Targeting Adaptive Mechanisms to ER Stress in Melanoma

Dr Xu Dong Zhang, Calvary Mater Newcastle Hospital, NSW

 

Chromosome ends in human health and disease
Professor Elizabeth Blackburn, University of California, CA, USA

 

Improving Breast Cancer Outcomes in the Community: The contributions of global collaboration for clinical trials and translational research 

Professor John Forbes, The University of Newcastle, NSW, Australia